why choose us

Clinical Trials Search

Showing 8,030 of 132,656 result(s)
A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).

Status: Completed

Condition: Chronic Obstructive Pulmonary Disease

Interventions: Randomized participants will receive 2 inhalations of BGF MDI via oral inhalation twice daily (BID).

Date: 2023-09-28

An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia

Status: Completed

Condition: Schizophrenia

Interventions: An investigational prescription digital therapeutic in the form of a smartphone app.

Date: 2023-09-28

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Status: Completed

Condition: Metastatic Castration-resistant Prostate Cancer

Interventions: Specified dose on specified days.

Date: 2023-09-28

Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury

Status: Completed

Condition: Traumatic Brain Injury

Interventions:

Hyperpolarized Pyruvate (13C) Injection, containing spin-polarized ("hyperpolarized") [13C]pyruvate, is being studied as a diagnostic age

Date: 2023-09-28

Dose-Response Effect Exercise and Depression

Status: Completed

Condition: Depression

Interventions: Participants will be asked to perform a high-dose (HD) (i.e., 300 minutes of MVPA per week) of structured exercise for 10 weeks.
Exercise modalit

Date: 2023-09-28

Evaluation of the Electronic Cigarette Withdrawal Syndrome

Status: Completed

Condition: E-cigarette Use

Interventions: Blinded Nicotine Patch

Date: 2023-09-28

A Study of DCR-STAT3 in Adults With Solid Tumors

Status: Completed

Condition: Solid Tumor, Adult

Interventions: DCR-STAT3 is a sterile, preservative-free solution in WFI that will be diluted in a suitable admixture diluent (0.9% normal saline) prior to IV infusi

Date: 2023-09-28

VK2735 for Weight Management Phase 2

Status: Completed

Condition: Weight Loss

Interventions: VK2735 is a peptide GLP-1 and GIP dual agonist

Date: 2023-09-28

IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation

Status: Completed

Condition: Benign Prostatic Hyperplasia

Interventions: Simultaneous UroLift™ and Holmium Laser Enucleation of the Prostate (HoLEP) for the Treatment of BPH in Men with Prominent Median Lobe Desiring Preser

Date: 2023-09-28

tACS to Enhance Language Abilities

Status: NOT_YET_RECRUITING

Condition: Stroke

Interventions: Transcranial Alternating Current Stimulation (tACS) is a device that applies a low-intensity electrical current to the brain through electrodes on the

Date: 2023-09-28